In a landmark moment at the ESMO Congress 2025, pivotal studies have unveiled compelling evidence that a new class of ...

BERLIN -- Antibody-drug conjugates (ADCs) targeting Trop2 made a strong case as first-line standard of care for metastatic ...

ADC usage in breast cancer treatment increased 3.7-fold from 2021 to 2023, with significant reductions in median time to ...

Patients with an aggressive form of breast cancer will likely have new treatment options after AstraZeneca and Gilead ...

Chris Martin and Gwyneth Paltrow’s daughter Apple Martin delivered a surprise performance with Jade Street Oct. 17 ahead of the release of her new single with the musical duo.

Funding accelerates development of novel therapeutics to improve outcomes for patients with cancerCAMBRIDGE, Mass. & LONDON--(BUSINESS WIRE)--#ADC--Valink Therapeutics Inc. (“Valink”), a private ...

AstraZeneca and Daiichi Sankyo's Datroway (datopotamab deruxtecan) came out of the blocks strongly at the ESMO congress with ...

Patients with an aggressive form of breast cancer who are not candidates for immune checkpoint inhibitor therapy showed ...

New safety, efficacy and pharmacokinetic results presented from dose escalation portion of the studyAnti-tumour activity observed across all dose levels and in various tumour indicationsNEWCASTLE, ...

I went into cancer care and cancer research because, when I was a fellow, it was the medical specialty with the largest ...

At a global oncology conference in Berlin this weekend, AstraZeneca (AZN) (UK:AZN) announced successful trial results for several drugs treating breast cancer that the pharmaceutical said will play a ...

Dato-DXd showed a 43% reduction in disease progression risk and a 21% reduction in death risk compared to chemotherapy in TNBC patients ineligible for immunotherapy. The TROPION-Breast02 trial ...